Cargando…

Neoadjuvant Endocrine Therapy and Delays in Surgery for Ductal Carcinoma in Situ: Implications for the Coronavirus Pandemic

BACKGROUND: Surgical delays are associated with invasive cancer for patients with ductal carcinoma in situ (DCIS). During the Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) pandemic, neoadjuvant endocrine therapy (NET) was used as a bridge until postponed surgeries resumed. This study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Williams, Austin D., Chang, Cecilia, Sigurdson, Elin R., Wang, Chih-Hsiung, Aggon, Allison A., Hill, Maureen V., Porpiglia, Andrea, Bleicher, Richard J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Breast Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504964/ https://www.ncbi.nlm.nih.gov/pubmed/34635974 http://dx.doi.org/10.1245/s10434-021-10883-5

Ejemplares similares

ASO Visual Abstract: Neoadjuvant Endocrine Therapy and Delays in Surgery for Ductal Carcinoma in Situ: Implications for the Coronavirus Pandemic
por: Williams, Austin D., et al.
Publicado: (2021)

Preoperative Delays in the Treatment of DCIS and the Associated Incidence of Invasive Breast Cancer
por: Ward, William H., et al.
Publicado: (2019)

A tool to predict disparities in the timeliness of surgical treatment for breast cancer patients in the USA
por: Verdone, Christopher G., et al.
Publicado: (2022)

Contralateral parenchymal enhancement on breast MRI before and during neoadjuvant endocrine therapy in relation to the preoperative endocrine prognostic index
por: Ragusi, Max A. A., et al.
Publicado: (2020)

Breast Reconstruction in Inflammatory Breast Cancer: An Analysis of Predictors, Trends, and Survival from the National Cancer Database
por: Karadsheh, Murad J., et al.
Publicado: (2021)

Surgical Management of Axilla Following Neoadjuvant Endocrine Therapy
por: Murphy, Brenna M., et al.
Publicado: (2021)

Tamoxifen Initiation After Ductal Carcinoma In Situ
por: Nichols, Hazel B., et al.
Publicado: (2016)

Invasive Mucinous Carcinoma Arising in Ectopic Axillary Breast Tissue: A Case Report and Literature Review
por: Nardello, Salvatore M., et al.
Publicado: (2015)

Breast Ductal Carcinoma in Situ: Morphologic and Kinetic MRI Findings
por: Nadrljanski, Mirjan M., et al.
Publicado: (2013)

An Unusual Presentation of Extensive Ductal Carcinoma in Situ Accompanying Invasive Ductal Carcinoma on MRI: A Case Report
Publicado: (2022)

Preoperative breast magnetic resonance imaging in patients with ductal carcinoma in situ: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC)
por: Canelo-Aybar, Carlos, et al.
Publicado: (2021)

Effectiveness of a Short Duration of Neoadjuvant Endocrine Therapy in Patients with HR+ Breast Cancer—An NCDB Analysis (2004–2016)
por: Goldbach, Macy M., et al.
Publicado: (2021)

Neoadjuvant Endocrine Therapy as an Alternative to Neoadjuvant Chemotherapy Among Hormone Receptor-Positive Breast Cancer Patients: Pathologic and Surgical Outcomes
por: Cao, Lifen, et al.
Publicado: (2021)

Axillary Response in Patients Undergoing Neoadjuvant Endocrine Treatment for Node-Positive Breast Cancer: Systematic Literature Review and NCDB Analysis
por: Stafford, Arielle, et al.
Publicado: (2020)

Breast Reconstruction in Inflammatory Breast Cancer: An Analysis of Predictors, Trends, and Survival from the National Cancer Database
por: Karadsheh, Murad J., et al.
Publicado: (2020)

Treatment times in breast cancer patients receiving neoadjuvant vs adjuvant chemotherapy: Is efficiency a benefit of preoperative chemotherapy?
por: Melchior, Nicole M., et al.
Publicado: (2020)

Differences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast Cancer
por: Truin, W., et al.
Publicado: (2015)

Delayed Sentinel Lymph Node Dissection in Patients with a Preoperative Diagnosis of Ductal Cancer In Situ by Preoperative Injection with Superparamagnetic Iron Oxide (SPIO) Nanoparticles: The SentiNot Study
por: Karakatsanis, Andreas, et al.
Publicado: (2023)

Pathological and Biological Differences Between Screen-Detected and Interval Ductal Carcinoma in situ of the Breast
por: de Roos, Marnix A., et al.
Publicado: (2007)

Associations Between Sentinel Lymph Node Biopsy and Complications for Patients with Ductal Carcinoma In Situ
por: Killelea, Brigid K., et al.
Publicado: (2018)

Hormone Receptor Subtype in Ductal Carcinoma in Situ: Prognostic and Predictive Roles of the Progesterone Receptor
por: Hwang, Ki‐Tae, et al.
Publicado: (2021)

Comparison of Local Recurrence After Simple and Skin-Sparing Mastectomy Performed in Patients with Ductal Carcinoma In Situ
por: Timbrell, Simon, et al.
Publicado: (2016)

Radioactive Seed Versus Wire-Guided Localization for Ductal Carcinoma in Situ of the Breast: Comparable Resection Margins
por: Agahozo, Marie Colombe, et al.
Publicado: (2020)

Ductal carcinoma in situ arises from microglandular adenosis and atypical microglandular adenosis in a young woman
por: Thu Huong, Nguyen, et al.
Publicado: (2023)

Long-Term Outcome of Neoadjuvant Endocrine Therapy with Aromatase Inhibitors in Elderly Women with Hormone Receptor-Positive Breast Cancer
por: Grassadonia, Antonino, et al.
Publicado: (2014)

Clinical Utility of the 12-Gene DCIS Score Assay: Impact on Radiotherapy Recommendations for Patients with Ductal Carcinoma In Situ
por: Manders, Jennifer B., et al.
Publicado: (2016)

Bilateral Triple Negative Invasive Ductal Breast Carcinoma in a BRCA1 Mutation Carrier with Discrepant Pathologic Response to Neoadjuvant Chemotherapy
Publicado: (2020)

The Clinical Utility of DCISionRT(®) on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery
por: Shah, Chirag, et al.
Publicado: (2021)

Predicting Lymph Node Metastases in Patients with Biopsy-Proven Ductal Carcinoma In Situ of the Breast: Development and Validation of the DCIS-met Model
por: Meurs, Claudia J. C., et al.
Publicado: (2022)

Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular Subtyping
por: Whitworth, Pat, et al.
Publicado: (2016)

ASO Author Reflections: Neoadjuvant Endocrine Therapy: A Pill in Time Saves Nine
por: Williams, Austin D., et al.
Publicado: (2022)

Validation and Clinical Utility of a Prediction Model for the Risk of Upstaging to Invasive Breast Cancer After a Biopsy Diagnosis Ductal Carcinoma In Situ
por: Meurs, Claudia J. C., et al.
Publicado: (2023)

Investigating the prediction value of multiparametric magnetic resonance imaging at 3 T in response to neoadjuvant chemotherapy in breast cancer
por: Minarikova, Lenka, et al.
Publicado: (2016)

Improving SIEA Perfusion through the Delay Phenomenon
por: Allen, Robert J., et al.
Publicado: (2022)

Characteristics of ultrasonographic images of ductal carcinoma in situ with abnormalities of the ducts
por: Ban, Kanako, et al.
Publicado: (2019)

The Use of Local Perforator Flaps in Delayed or Secondary Breast Reconstruction
por: Quinn, Edel Marie, et al.
Publicado: (2020)

Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging
por: Fangberget, A., et al.
Publicado: (2010)

The Hybrid Delay: A New Approach for Nipple-sparing Mastectomy in Macromastia
por: Jensen, Jay Arthur, et al.
Publicado: (2020)

Free Silicone Injections to the Breast: Delayed Complications and Surgical Management of Sequelae
por: Bhardwaj, Priya, et al.
Publicado: (2020)

Surgical Nipple Delay and its Expanded Indications for Nipple-sparing Mastectomy
por: Lee, Phoebe L., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dfbt02f6otf3kjs77oebroep8l